Leukemia's Lab Diagnosis (ALL, AML, CLL, and CML)
Laboratory Diagnosis of Leukemias
I. Acute Myeloid Leukemia (AML)
1. Complete Blood Count (CBC)
- Anemia – normocytic, normochromic (↓ RBCs, Hb)
- Thrombocytopenia – ↓ platelet count
- Leukocytosis – ↑ WBC count (in most cases)
- Blast cells in peripheral smear – >20% blasts (WHO criterion)
2. Peripheral Blood Smear
-
Myeloblasts – large cells with:
- High N:C ratio
- Fine chromatin
- 1–4 nucleoli
- Auer rods – (needle-like azurophilic granules; diagnostic of myeloid lineage)
3. Bone Marrow Aspiration & Biopsy
- Hypercellular marrow
- >20% myeloblasts
- Suppressed normal hematopoiesis
4. Cytochemistry
- Myeloperoxidase (MPO) positive – (confirms myeloid origin)
- Sudan Black B (SBB) positive
- Non-specific esterase negative
5. Immunophenotyping (Flow Cytometry)
- CD13, CD33, CD117 – markers of myeloid lineage
- HLA-DR, CD34 (stem cell markers)
6. Cytogenetic & Molecular Studies
- t(8;21), inv(16), t(15;17) (PML-RARA in APL subtype)
- FLT3, NPM1 mutations (prognostic markers)
II. Acute Lymphoblastic Leukemia (ALL)
1. Complete Blood Count (CBC)
- Anemia
- Thrombocytopenia
- Variable WBC count – may be low, normal, or high
- Blasts in peripheral blood – lymphoblasts
2. Peripheral Blood Smear
-
Lymphoblasts – small to medium cells with:
- Scant cytoplasm
- Condensed chromatin
3. Bone Marrow Aspiration
- >20% lymphoblasts
- Suppressed normal hematopoiesis
4. Cytochemistry
- MPO negative
- SBB negative
- PAS positive (Periodic acid–Schiff reaction)
5. Immunophenotyping
- B-ALL: CD10, CD19, CD22, TdT+
- T-ALL: CD3, CD7, TdT+
6. Cytogenetics
- t(12;21) – good prognosis
- t(9;22) BCR-ABL (Philadelphia chromosome) – poor prognosis
- Hyperdiploidy or hypodiploidy – prognostic value
III. Chronic Myeloid Leukemia (CML)
1. CBC
- Marked leukocytosis (often >100,000/µL)
- Anemia – mild to moderate
- Thrombocytosis – common in early phase
2. Peripheral Blood Smear
- All stages of myeloid maturation present:
- Myeloblasts, promyelocytes, myelocytes, metamyelocytes, neutrophils, basophils
- Basophilia & eosinophilia
- Few blasts (<10%)
3. Bone Marrow Aspiration
- Hypercellular with granulocytic hyperplasia
- Myeloid to erythroid (M:E) ratio increased
4. LAP Score (Leukocyte Alkaline Phosphatase)
-
Low in CML (differentiates from leukemoid reaction)
5. Cytogenetics / Molecular
-
Philadelphia chromosome (t(9;22)(q34;q11))
- BCR-ABL fusion gene
- Detected by FISH, RT-PCR
IV. Chronic Lymphocytic Leukemia (CLL)
1. CBC
- Absolute lymphocytosis (>5,000/µL mature lymphocytes)
- Anemia and thrombocytopenia – late stages
2. Peripheral Blood Smear
- Small mature lymphocytes with clumped chromatin
- Smudge cells – (ruptured lymphocytes during smear prep)
3. Bone Marrow
- Hypercellular marrow with lymphoid infiltration
- Pattern: nodular, interstitial, or diffuse infiltration
4. Immunophenotyping
- CD5+, CD19+, CD20+, CD23+
- Weak surface immunoglobulin
5. Cytogenetic Abnormalities
- del(13q), trisomy 12, del(11q), del(17p)
- ZAP-70, CD38 expression – adverse prognosis
Comparative Table:
Feature / Test | Acute Myeloid Leukemia (AML) | Acute Lymphoblastic Leukemia (ALL) | Chronic Myeloid Leukemia (CML) | Chronic Lymphocytic Leukemia (CLL) |
---|---|---|---|---|
Age group commonly affected | Adults (especially >40 years) | Children (peak at 2–5 years) | Adults (typically 40–60 years) | Elderly (median age ~70 years) |
Complete Blood Count (CBC) | ↓ Hemoglobin, ↓ Platelets, ↑ or ↓ WBCs with circulating myeloblasts | ↓ Hemoglobin, ↓ Platelets, ↑ or ↓ WBCs with circulating lymphoblasts | ↑↑ WBCs (often >100,000/µL), mild anemia, normal or ↑ platelets | ↑ Lymphocyte count (>5,000/µL), late ↓ Hb and platelets |
Peripheral Blood Smear | Large myeloblasts with high N:C ratio, fine chromatin, nucleoli, Auer rods | Small-medium lymphoblasts with scant cytoplasm, condensed chromatin, indistinct nucleoli | Myeloid precursors at all stages: myeloblasts → neutrophils; basophilia, eosinophilia | Small mature lymphocytes, smudge cells (fragile cells ruptured on smear) |
Blasts in Peripheral Smear | >20% myeloblasts | >20% lymphoblasts | <10% blasts | Rare or absent |
Bone Marrow Examination | Hypercellular, >20% myeloblasts, ↓ normal hematopoiesis | Hypercellular, >20% lymphoblasts, ↓ normal hematopoiesis | Hypercellular with granulocytic hyperplasia, ↑ M:E ratio | Hypercellular with diffuse/nodular lymphocytic infiltration |
Cytochemistry | MPO+, Sudan Black B+, NSE− | MPO−, Sudan Black B−, PAS+ | MPO weakly positive | Negative |
Immunophenotyping (Flow Cytometry) | CD13, CD33, CD117, HLA-DR, CD34 (stem/myeloid markers) | B-ALL: CD10, CD19, CD22, TdT+; T-ALL: CD3, CD7, TdT+ | Myeloid markers; BCR-ABL expression (fusion protein) | CD19, CD20, CD5, CD23, weak surface Ig |
Cytogenetics / Molecular Testing | t(8;21), inv(16), t(15;17/PML-RARA), FLT3, NPM1 mutations | t(12;21) (good prognosis), t(9;22) BCR-ABL (poor prognosis), hyper-/hypodiploidy | Philadelphia chromosome t(9;22) → BCR-ABL fusion gene | del(13q), del(11q), del(17p), trisomy 12; ZAP-70+, CD38+ (poor prognosis) |
Leukocyte Alkaline Phosphatase (LAP) | Not used | Not used | ↓ LAP score (helps differentiate from leukemoid reaction) | Normal |
Special Findings | Auer rods are pathognomonic | PAS block positivity in blasts | Basophilia, Eosinophilia, BCR-ABL gene detected by FISH or PCR | Smudge cells, clonal B-lymphocytes, hypogammaglobulinemia |
Other Laboratory Findings | ↑ LDH, ↑ uric acid (due to tumor lysis), prolonged PT/PTT in APL subtype | ↑ LDH, ↑ uric acid; CSF analysis if CNS involvement suspected | ↑ LDH, ↑ uric acid, possible splenomegaly on imaging | ↑ LDH, ↓ immunoglobulin levels (may lead to recurrent infections) |
Key Terms:
- Blasts: Immature precursor cells; high numbers in blood suggest acute leukemia.
- Auer Rods: Needle-like azurophilic granules in AML myeloblasts (confirm myeloid lineage).
- MPO (Myeloperoxidase): Enzyme present in myeloid cells; positive in AML.
- PAS (Periodic Acid–Schiff): Stains glycogen in lymphoblasts; positive in ALL.
- CD Markers: Cell surface proteins used to identify lineage (e.g., CD19 = B-cells).
- Philadelphia Chromosome (t(9;22)): Translocation forming BCR-ABL, found in CML (and some ALL).
- Smudge Cells: Damaged fragile lymphocytes, common in CLL.
- ZAP-70 and CD38: Predict poor prognosis in CLL.
Comments
Post a Comment